Llwytho...
Romidepsin Controls Chronic Lymphocytic Leukemia in a Patient with Mycosis Fungoides
Romidepsin belongs to a class of medications called histone deacetylase inhibitors and is currently approved for treatment of cutaneous and peripheral T-cell lymphomas. Romidepsin was previously investigated for the treatment of chronic lymphocytic leukemia (CLL), and demonstrated potential benefit,...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Hematol Rep |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
PAGEPress Publications, Pavia, Italy
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5136743/ https://ncbi.nlm.nih.gov/pubmed/27994839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2016.6840 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|